Printable version The Global HIV Vaccine Enterprise was conceived in 2003 to bring new focus, cooperation and expanded resources to HIV vaccine research. Since its inception, the Enterprise has formed an alliance of independent organizations that includes many of the leading AIDS vaccine research institutions in the world.
The Founding Members of the Enterprise include:
- Dr. Seth Berkley (International AIDS Vaccine Initiative/IAVI)
- Prof. Jean-François Delfraissy (French National Agency for Research on AIDS and Viral Hepatitis/ANRS)
- Dr. Anthony Fauci (National Institutes of Health, US Department of Health and Human Services/NIH/NIAID]
- Ms. Daisy Mafubelu (WHO-UNAIDS)
- Dr. Ruxandra Draghia-Akli (European Commission)
- Dr. Mark Walport (Wellcome Trust)
- Dr. Tachi Yamada and Dr. José Esparza (The Bill & Melinda Gates Foundation)
The Board was established to govern the organization. The Directors adhere to a Conflict of Interest policy.
Enterprise Board Members include:
- Dr. David Cook (Treasurer and Secretary)
- Prof. Jean François Delfraissy (National Agency for AIDS Research and Viral Hepatitis in France)
- Dr. Carl Dieffenbach (National Institutes of Health, US Department of Health and Human Services (NIH/NIAID)
- Dr. Nina Russell (The Bill & Melinda Gates Foundation) (President)
- Ms. Margaret McGlynn (International AIDS Vaccine Initiative)
- COL. Nelson Michael (U.S. Military HIV Research Program)
- Dr. Gerald Voss (GlaxoSmithKline Biologicals)
- Mr. Mitchell Warren (AVAC: Global Advocacy for HIV Prevention)
